Posts

Showing posts from September, 2025

Move over Murdochs the Ellisons are the new family dynasty shaking up US media

Image
Natalie ShermanBusiness reporter Larry Ellison at the White House with Donald Trump in January 2025 Tech billionaire Larry Ellison and his son, Hollywood producer David, have long walked the halls of power in America's entertainment and business worlds, rubbing shoulders with celebrities and heads of state. But it's not the Hollywood glamour of David Ellison's film production firm Skydance, nor Larry's lucrative days as CEO of software giant Oracle, that are dominating the headlines. It's the family's bid to create a new media empire – one that some say could pose a threat to Rupert Murdoch's long-held dominance in the US media landscape. The Ellisons have just completed a $7bn deal to buy a 66% stake in film and TV production company Skydance, taking the family's media interests to new heights. Larry Ellison, the billionaire co-founder of Oracle, will sit on the board of the enlarged company while his son, David, will be chai...

Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it - AP News

WASHINGTON (AP) When President Donald Trump's administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts including the physician who actually proposed the idea. Dr. Rosario Montella proposed the use of sodium benzoate as a potential treatment for autism spectrum disorder in 2015, long before Trump took office. But when the administration announced the decision in March, Trump touted it as a major breakthrough, suggesting it could be approved 'within two weeks', Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it - AP News However, many in the autism community are urging caution, pointing out that there's currently no scientific evidence to support the claim that the drug is effective against autism. In fact, an independent study published in the journal Translational Psychiatry last fall found that sodium benzoate had little to no effect on au...

Nvidia’s Massive OpenAI Deal Fuels ‘Circular’ Financing Concerns - Bloomberg.com

Image
Three years after OpenAI and Nvidia Corp. helped kick off the global artificial intelligence frenzy, the two firms are joining forces to pave the way for a more costly phase of development with a deal that has drawn attention to "circular" financial practices. OpenAI, the privately-held AI research lab behind the popular chatbot ChatGPT, said on Tuesday it has struck a deal with Nvidia – one of the world's leading manufacturers of computer chips and other technologies – to create a new generation of AI hardware. The agreement, worth an undisclosed amount, is meant to help Nvidia produce more powerful AI chips and boost the development of OpenAI's language models. The deal is significant because it highlights the close relationship between Nvidia and OpenAI, as well as the financial backing they have received over the years. Both companies have been at the forefront of the development of artificial intelligence and have received significant financing from in...

America Has a New Top-Selling Beer

Image
Perhaps with Leo Messi as the face of Michelob Ultra, it was only a matter of time before the light lager achieved GOAT status. The Anheuser-Busch beer has overtaken rival Modelo Especial in US retail sales, according to market research firm IRI. The data reveals that Michelob Ultra has taken the top spot in the US beer market, surpassing Modelo Especial. This shift highlights the growing demand for light and low-calorie beers in the US. The popularity of Michelob Ultra can be attributed to its refreshing taste and marketing campaigns featuring notable celebrities. As the summer months approach, it will be interesting to see if Michelob Ultra continues to hold its position as the top-selling beer in America.